Evaluating Ventricular Arrhythmia in Subjects With Implantable Cardioverter Defibrillator or Cardiac Resynchronization Therapy-Defibrillator
Condition:   Ventricular ArrhythmiaInterventions:   Drug: GS-6615;   Drug: Placebo to match GS-6615Sponsor:   Gilead SciencesRecruiting - verified November 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 2, 2014 Category: Research Source Type: clinical trials

Evaluating Ventricular Arrhythmia in Subjects With Implantable Cardioverter Defibrillator or Cardiac Resynchronization Therapy-Defibrillator
Condition:   Ventricular ArrhythmiaInterventions:   Drug: GS-6615;   Drug: Placebo to match GS-6615Sponsor:   Gilead SciencesRecruiting - verified October 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 2, 2014 Category: Research Source Type: clinical trials

Evaluating Ventricular Arrhythmia in Subjects With Implantable Cardioverter Defibrillator or Cardiac Resynchronization Therapy-Defibrillator
Condition:   Ventricular ArrhythmiaInterventions:   Drug: GS-6615;   Drug: Placebo to match GS-6615Sponsor:   Gilead SciencesRecruiting - verified November 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 2, 2014 Category: Research Source Type: clinical trials

Evaluating Ventricular Arrhythmia in Subjects With Implantable Cardioverter Defibrillator or Cardiac Resynchronization Therapy-Defibrillator
Condition:   Ventricular ArrhythmiaInterventions:   Drug: GS-6615;   Drug: Placebo to match GS-6615Sponsor:   Gilead SciencesRecruiting - verified December 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 2, 2014 Category: Research Source Type: clinical trials